FY2025 EPS Forecast for Olema Pharmaceuticals Cut by Analyst
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Free Report) – Investment analysts at Lifesci Capital decreased their FY2025 earnings per share (EPS) estimates for Olema Pharmaceuticals in a research report issued on Wednesday, March 19th. Lifesci Capital analyst S. Slutsky now anticipates that the company will post earnings per share of ($2.28) for the year, down from […]
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Free Report) – Investment analysts at Lifesci Capital decreased their FY2025 earnings per share (EPS) estimates for Olema Pharmaceuticals in a research report issued on Wednesday, March 19th. Lifesci Capital analyst S. Slutsky now anticipates that the company will post earnings per share of ($2.28) for the year, down from […]
-logo-1200x675.PNG?v=20210211152252&w=240&h=240&zc=2){kind=logo}
